Not recruitingISRCTN10628149

A randomised, double-blind, placebo-controlled clinical trial of a Compound Herbal Preparation (CHP) in the treatment of children with Attention-Deficit Hyperactivity Disorder (ADHD)

Research studyAges 6–12Israel

The study in practice

Understand this study

This study is for people with ADHD. Listed age limits: 6 years to 12 years. Other eligibility criteria apply.

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Study start dateNot clearly listed

Recruitment status: Not recruiting
Enrollment listed in the registry: Not clearly listed
Sponsor: Etz-HaChayim Clinic (Israel)
Sponsor type: Hospital / academic medical center
Study type: Other
Intervention type: Other / unclear
Study phase: Not clearly listed
Locations: Israel
Age range: From 6 Years to 12 Years
Official registry ID: ISRCTN10628149
Official title: Show the full official title
A randomised, double-blind, placebo-controlled clinical trial of a Compound Herbal Preparation (CHP) in the treatment of children with Attention-Deficit Hyperactivity Disorder (ADHD)

Leave your email and we’ll get in touch to discuss your questions and possible next steps.

Not recruiting

Israel

A listed location does not confirm current availability.

FAQ

Who is behind this study?

The study sponsor is Etz-HaChayim Clinic (Israel), a hospital or academic medical center.

Who can participate?

This study is for people with ADHD. Listed age limits: 6 years to 12 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as not recruiting.

Explore other studies

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.